Sales Growth YoY (Last 12 Months): Liminatus Pharma (LIMN)

Public company logo of Liminatus (LIMN)

The investment cycle of Liminatus Pharma (LIMN) is protected by patents in narrow niches, which mitigates financial risks. This trailing twelve-month revenue chart visualizes these fluctuations, where 0.00 is recorded as the baseline value. Growth is driven by the development of CAR-T therapy for the gut and interest from industry behemoths, although success depends on the outcome of the scientific race in the immunotherapy segment.

Liminatus Pharma LLC (LIMN) Revenue Growth YoY (Last 12 Months): for the period 11/23/2025 - 11/18/2026

Liminatus Pharma LLC (LIMN) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Liminatus Pharma
Product sample of liminatuspharma.com

Liminatus Pharma is conducting high-tech immunotherapy development that depends on the cross-border logistics of biomaterials. The sales_yy_ttm_co indicator measures trailing twelve-month revenue dynamics, capturing the pace of business expansion on a daily basis. This metric allows for the filtering of market noise, revealing the actual resilience of sales to geopolitical sanctions. Investors are assessing the company's ability to scale despite disruptions to clinical trials. The trajectory of year-over-year sales volume growth on a trailing twelve-month basis confirms the preservation of competitive advantages.

Competitors of Liminatus Pharma (LIMN)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|IOBT (iobiotech.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) Sutro Biopharma Inc.|Sales Growth YoY (Last Twelve Months) MiNK Therapeutics (INKT)|HOWL: Trailing Twelve Months Sales Growth|Immix Biopharma - Revenue Growth YoY (Last 12 Months)|ALX Oncology (ALXO) - Trailing Twelve Months Revenue Growth|CUE: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth PDSB|sonnetbio.com (SONN) - Sales Growth YoY (Last Twelve Months)|MAIA Biotechnology Inc (MAIA) - Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)